0,923  0,003  Teratogen
0,913  0,004  Embryotoxic
0,899  0,003  Vasodilator, coronary
0,889  0,007  Apoptosis agonist
0,840  0,004  Antineoplastic (melanoma)
0,833  0,006  Antineoplastic (lung cancer)
0,829  0,005  Antineoplastic (ovarian cancer)
0,823  0,003  Cytotoxic
0,792  0,005  Mutagenic
0,752  0,010  Antineoplastic (colorectal cancer)
0,751  0,010  Antineoplastic (colon cancer)
0,733  0,006  Antibacterial
0,673  0,003  Antineoplastic antibiotic
0,671  0,004  Restenosis treatment
0,671  0,024  Transcription factor NF kappa B inhibitor
0,646  0,005  Vasodilator
0,626  0,006  Hypoxia-inducible factor 1 alpha inhibitor
0,615  0,011  Immunosuppressant
0,601  0,015  Atherosclerosis treatment
0,590  0,037  Antineoplastic (breast cancer)
0,544  0,032  Antileukemic
0,486  0,024  Antifungal
0,481  0,023  Antineoplastic (pancreatic cancer)
0,473  0,026  Antineoplastic (cervical cancer)
0,450  0,015  Antineoplastic (liver cancer)
0,435  0,004  Antibiotic
0,457  0,028  Caspase 3 stimulant
0,431  0,030  Antineoplastic (glioma)
0,424  0,023  Antineoplastic (lymphoma)
0,421  0,034  Antineoplastic (brain cancer)
0,398  0,028  Antineoplastic (glioblastoma multiforme)
0,406  0,038  ICAM1 expression inhibitor
0,394  0,026  Nitric oxide antagonist
0,360  0,001  Microtubule formation inhibitor
0,377  0,036  Sensitization
0,349  0,019  Contraceptive
0,350  0,021  Antiviral (HIV)
0,374  0,046  NOS3 expression inhibitor
0,364  0,038  Antineoplastic (multiple myeloma)
0,355  0,049  Analeptic
0,301  0,010  Cell adhesion inhibitor
0,343  0,058  Respiratory analeptic
0,328  0,055  Sodium/bile acid cotransporter inhibitor
0,310  0,050  Tumour necrosis factor alpha release inhibitor
0,323  0,076  Prostate cancer treatment
0,278  0,032  UGT2B7 substrate
0,390  0,145  Antiinflammatory
0,309  0,064  Antineoplastic (endocrine cancer)
0,327  0,087  CYP3A4 substrate
0,266  0,025  Interferon gamma antagonist
0,273  0,042  UDP-glucuronosyltransferase substrate
0,349  0,118  Calcium channel L-type activator
0,282  0,058  Proliferative diseases treatment
0,237  0,017  ATPase inhibitor
0,258  0,044  UGT1A1 substrate
0,258  0,045  Peptidyltransferase inhibitor
0,239  0,029  Protein kinase stimulant
0,290  0,088  AR expression inhibitor
0,264  0,071  Antineoplastic (renal cancer)
0,278  0,091  Interleukin 2 agonist
0,243  0,062  Antimitotic
0,298  0,132  TNF expression inhibitor
0,202  0,038  UGT2B9 substrate
0,200  0,043  Toxic, respiratory center
0,217  0,060  Chemopreventive
0,187  0,037  Antifungal enhancer
0,142  0,009  ATPase (Vacuolar H+) inhibitor
0,151  0,029  Protease inhibitor
0,216  0,096  Antineoplastic (non-small cell lung cancer)
0,202  0,084  Antineoplastic enhancer
0,140  0,025  Androgen antagonist
0,209  0,095  NOS2 expression inhibitor
0,146  0,037  Contraceptive female
0,185  0,076  Hepatoprotectant
0,188  0,086  Pneumotoxic
0,160  0,066  Antiviral (Influenza A)
0,102  0,014  Androgen agonist
0,188  0,104  VCAM1 expression inhibitor
0,119  0,036  Antihypermotility
0,195  0,118  Antioxidant
0,115  0,040  Antineoplastic alkaloid
0,117  0,043  Anabolic
0,169  0,096  Antiviral (Influenza)
0,142  0,073  Antifungal (Cryptococcus)
0,084  0,018  Protein 50S ribosomal subunit inhibitor
0,170  0,111  Angiogenesis stimulant
0,134  0,077  Antineoplastic (squamous cell carcinoma)
0,124  0,077  Antiacne
0,110  0,067  Neutropenia treatment
0,186  0,144  DNA synthesis inhibitor
0,086  0,045  T cell inhibitor
0,058  0,017  Microtubule stabilization
0,081  0,040  Antitreponemal
0,092  0,060  SULT1E1 substrate
0,036  0,004  Progesterone receptor B antagonist
0,135  0,105  Melanin inhibitor
0,162  0,132  Platelet antagonist
0,042  0,013  Tubulin agonist
0,146  0,117  Catenin beta inhibitor
0,136  0,109  Prostate disorders treatment
0,031  0,004  Antibiotic Macrolide-like
0,049  0,023  HIV-1 protease inhibitor
0,165  0,139  Cytostatic
0,078  0,053  Somatostatin 1 agonist
0,153  0,130  Antiparasitic
0,181  0,159  Chemoprotective
0,200  0,179  Apoptosis antagonist
0,056  0,036  Postmenopausal disorders treatment
0,118  0,098  UGT2B15 substrate
0,063  0,054  Hypercalcemia treatment
0,071  0,064  Narcotic antagonist
0,180  0,174  UGT2B4 substrate
0,043  0,038  Parathyroid hormone antagonist
0,029  0,025  Cyclophilin A inhibitor
0,133  0,132  Antihelmintic
0,065  0,065  Na+ K+ transporting ATPase inhibitor

